Search

everythinglearnresearchcommunity

for

Search:↓

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Dissolving microneedles show promise for treating hair loss but need more research for practical use.

Visual signs are crucial for accurately diagnosing and treating different types of hair loss in Black patients.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Alopecia areata causes a significant economic burden in Japan, mainly due to productivity loss.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Activated and non-activated PRP are equally safe and effective for treating alopecia areata.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

New small molecule drugs could help treat hair loss.